Hubei Guangji Pharmaceutical Co., Ltd. (SHE:000952)
China
· Delayed Price · Currency is CNY 7.27
-0.11 (-1.49%)
Apr 29, 2026, 3:04 PM CST
SHE:000952 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 2,559 | 2,438 | 2,162 | 2,828 | 2,711 | 2,694 | Upgrade
|
| Market Cap Growth | 34.21% | 12.74% | -23.55% | 4.31% | 0.66% | 5.00% | Upgrade
|
| Enterprise Value | 3,439 | 2,919 | 3,232 | 3,737 | 2,862 | 2,743 | Upgrade
|
| Last Close Price | 7.38 | 7.03 | 6.18 | 7.99 | 7.66 | 7.77 | Upgrade
|
| PE Ratio | - | - | - | - | 53.87 | 24.46 | Upgrade
|
| PS Ratio | 4.01 | 3.91 | 3.39 | 3.83 | 3.40 | 3.43 | Upgrade
|
| PB Ratio | 4.31 | 3.89 | 2.01 | 2.03 | 1.82 | 1.86 | Upgrade
|
| P/TBV Ratio | 6.08 | 5.42 | 2.62 | 2.47 | 2.01 | 2.06 | Upgrade
|
| P/FCF Ratio | 40.63 | 98.34 | - | - | - | - | Upgrade
|
| P/OCF Ratio | 27.29 | 40.34 | 3299.14 | - | 60.15 | 35.48 | Upgrade
|
| EV/Sales Ratio | 5.39 | 4.68 | 5.06 | 5.07 | 3.59 | 3.49 | Upgrade
|
| EV/EBITDA Ratio | 56.35 | 61.36 | - | 155.43 | 19.27 | 15.40 | Upgrade
|
| EV/EBIT Ratio | - | - | - | - | 55.99 | 31.43 | Upgrade
|
| EV/FCF Ratio | 54.61 | 117.76 | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 2.09 | 2.07 | 0.81 | 0.63 | 0.44 | 0.26 | Upgrade
|
| Debt / EBITDA Ratio | 20.18 | 24.07 | - | 34.60 | 4.43 | 2.12 | Upgrade
|
| Debt / FCF Ratio | 19.68 | 52.37 | - | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | 1.53 | 1.63 | 0.53 | 0.33 | 0.16 | 0.06 | Upgrade
|
| Net Debt / EBITDA Ratio | 16.54 | 21.43 | -10.71 | 19.07 | 1.55 | 0.48 | Upgrade
|
| Net Debt / FCF Ratio | 14.45 | 41.14 | -3.67 | -0.64 | -1.45 | -4.10 | Upgrade
|
| Asset Turnover | 0.25 | 0.24 | 0.22 | 0.27 | 0.35 | 0.39 | Upgrade
|
| Inventory Turnover | 1.69 | 1.58 | 1.69 | 2.11 | 2.64 | 2.97 | Upgrade
|
| Quick Ratio | 0.42 | 0.39 | 0.58 | 0.83 | 1.11 | 0.91 | Upgrade
|
| Current Ratio | 0.62 | 0.61 | 0.99 | 1.25 | 1.54 | 1.31 | Upgrade
|
| Return on Equity (ROE) | -53.08% | -51.55% | -25.53% | -10.57% | 3.24% | 7.51% | Upgrade
|
| Return on Assets (ROA) | -2.49% | -2.74% | -4.66% | -2.15% | 1.41% | 2.71% | Upgrade
|
| Return on Invested Capital (ROIC) | -6.57% | -6.82% | -12.43% | -5.30% | 2.49% | 5.13% | Upgrade
|
| Return on Capital Employed (ROCE) | -11.50% | -12.10% | -11.60% | -4.40% | 2.80% | 5.80% | Upgrade
|
| Earnings Yield | -15.63% | -16.59% | -13.66% | -4.96% | 1.86% | 4.09% | Upgrade
|
| FCF Yield | 2.46% | 1.02% | -7.13% | -25.28% | -5.85% | -0.77% | Upgrade
|
| Dividend Yield | - | - | - | - | - | 0.77% | Upgrade
|
| Payout Ratio | - | - | - | - | 79.95% | 32.38% | Upgrade
|
| Buyback Yield / Dilution | 0.94% | -0.21% | 0.60% | -0.36% | -2.54% | -2.85% | Upgrade
|
| Total Shareholder Return | 0.94% | -0.21% | 0.60% | -0.36% | -2.54% | -2.08% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.